|
1
|
Bilezikian JP, Khan AA and Potts JT Jr:
Third International Workshop on the Management of Asymptomatic
Primary Hyperthyroidism. Guidelines for the management of
asymptomatic primary hyperparathyroidism: Summary statement from
the third international workshop. J Clin Endocrinol Metab.
94:335–339. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bilezikian JP, Khan A, Potts JT Jr, Brandi
ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L,
et al: Hypoparathyroidism in the adult: Epidemiology, diagnosis,
pathophysiology, target-organ involvement, treatment, and
challenges for future research. J Bone Miner Res. 26:2317–2337.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Clarke BL, Brown EM, Collins MT, Jüppner
H, Lakatos P, Levine MA, Mannstadt MM, Bilezikian JP, Romanischen
AF and Thakker RV: Epidemiology and diagnosis of
hypoparathyroidism. J Clin Endocrinol Metab. 101:2284–2299.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Siraj N, Hakami Y and Khan A: Medical
hypoparathyroidism. Endocrinol Metab Clin North Am. 47:797–808.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brinkane A, Peschard S, Leroy-Terquem E,
Bergheul S, Raheriarisoa H, Hubert N, Crickx L and Levy R:
Association rare d'une hypoparathyroïdie et d'une sarcoïdose
médiastino-pulmonaire: Rare association of hypoparathyroidism and
mediastinal-pulmonary sarcoidosis. Ann Med Interne (Paris).
152:63–64. 2001.PubMed/NCBI(In French).
|
|
6
|
Goddard CJ, Mbewu A and Evanson JM:
Symptomatic hypocalcaemia associated with metastatic invasion of
the parathyroid glands. Br J Hosp Med. 43(72)1990.PubMed/NCBI
|
|
7
|
Bilezikian JP: Hypoparathyroidism. J Clin
Endocrinol Metab. 105:1722–1736. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shoback D: Clinical practice.
Hypoparathyroidism. N Engl J Med. 359:391–403. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Georgakopoulou VE, Avramopoulos P,
Papalexis P, Bitsani A, Damaskos C, Garmpi A, Gkoufa A, Garmpis N,
Mantzouranis K, Chlapoutakis S, et al: Exacerbation of
bronchiectasis by Pseudomonas putida complicating COVID-19
disease: A case report. Exp Ther Med. 22(1452)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen Y, Guo Y, Pan Y and Zhao ZJ:
Structure analysis of the receptor binding of 2019-nCoV. Biochem
Biophys Res Commun. 525:135–140. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lazartigues E, Qadir MMF and
Mauvais-Jarvis F: Endocrine significance of SARS-CoV-2's reliance
on ACE2. Endocrinology. 161(bqaa108)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
He L, Ding Y, Zhang Q, Che X, He Y, Shen
H, Wang H, Li Z, Zhao L, Geng J, et al: Expression of elevated
levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+
cells in SARS patients: relation to the acute lung injury and
pathogenesis of SARS. J Pathol. 210:288–297. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Di Filippo L, Formenti AM, Rovere-Querini
P, Carlucci M, Conte C, Ciceri F, Zangrillo A and Giustina A:
Hypocalcemia is highly prevalent and predicts hospitalization in
patients with COVID-19. Endocrine. 68:475–478. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu J, Han P, Wu J, Gong J and Tian D:
Prevalence and predictive value of hypocalcemia in severe COVID-19
patients. J Infect Public Health. 13:1224–1228. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Elkattawy S, Alyacoub R, Ayad S, Pandya M
and Eckman A: A novel case of hypoparathyroidism secondary to
SARS-CoV-2 infection. Cureus. 12(e10097)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dianatfar M, Sanjari M and Dalfardi B:
Hypoparathyroidism after COVID-19 Pneumonia. Shiraz E-Med J.
22(e115832)2021.
|
|
17
|
Bossoni S, Chiesa L and Giustina A: Severe
hypocalcemia in a thyroidectomized woman with Covid-19 infection.
Endocrine. 68:253–254. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pla B, Silva M, Arranz A and Marazuela M:
Hipocalcemia severa y resistente al tratamiento en paciente con
neumonía bilateral COVID-19. Severe and treatment-resistant
hypocalcemia in patient with bilateral COVID-19 pneumonia.
Endocrinol Diabetes Nutr. 68:518–519. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bonnet JB, Berchoux E and Sultan A:
Decompensated primary hypoparathyroidism in a patient with
COVID-19. Ann Endocrinol (Paris). 82:123–124. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ding Y, He L, Zhang Q, Huang Z, Che X, Hou
J, Wang H, Shen H, Qiu L, Li Z, et al: Organ distribution of severe
acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV)
in SARS patients: Implications for pathogenesis and virus
transmission pathways. J Pathol. 203:622–630. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abobaker A and Alzwi A: The effect of
COVID-19 on parathyroid glands. J Infect Public Health. 14:724–725.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Guo Y, Korteweg C, McNutt MA and Gu J:
Pathogenetic mechanisms of severe acute respiratory syndrome. Virus
Res. 133:4–12. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu
SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report
of three COVID-19 cases by minimal invasive autopsies. Zhonghua
Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
24
|
Piticchio T, Le Moli R, Tumino D and
Frasca F: Relationship between betacoronaviruses and the endocrine
system: A new key to understand the COVID-19 pandemic-A
comprehensive review. J Endocrinol Invest. 44:1553–1570.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Krapf R, Jaeger P and Hulter HN: Chronic
respiratory alkalosis induces renal PTH-resistance,
hyperphosphatemia and hypocalcemia in humans. Kidney Int.
42:727–734. 1992.PubMed/NCBI View Article : Google Scholar
|
